Current articles and info about your health

Thursday, 20th November 2008

   home     about     authors     news     books     xml feed     sitemap     privacy     contact us

There are 6 users online

add to favorites
make home page


Addiction Issues
Aging
Allergies & Sinuses
Alternative Medicine
Beauty & Health
Books & Reading
Common Illnesses
Community Service
Diabetic Health
Dieting
Diseases
Environmental Health
Exercise and Fitness
Health Education
Health Industry
Health Insurance
Health Legal Issues
Health Technology
Healthcare Services
Healthy Eating
Medical Equipment & Products
Men's Health
Mental and Emotional Health
Muscle & Back Pain
Nutrition and Supplements
Pediatrics
Pet Health
Physical Therapy & Massage
Prevention Health
Vision Health
Weight Management
Women's Health

Our Newsletter

Sign up for our free
Health-Informant.com Ezine
Get all the latest Health news delivered right to your mailbox.


First Name:

Your Email:



We will never rent, share or sell your name to anyone else... ever! We respect your privacy!
  Other Resources


For other sources of health news, tips, and information, visit our resources page

 

  Submit an Article


Would you like to have your article posted? Click Here
 

 
 

Monoclonal Antibody Therapies Continue Rapid Growth in Cancer Market
Added: 06/28/2004
Type: Summary
Viewed: 884 time(s)
[ Not Rated Yet ]

How would you rate this article:    Bad Good   Go » 
Monoclonal Antibody Therapies Continue Rapid Growth in Cancer Market

 The worldwide market for cancer therapeutics based on monoclonal antibodies is continuing a dramatic growth curve, according to a new study released today from Kalorama Information. In only their third year on the market, revenues from monoclonals for the treatment of cancer are growing at nearly 40% annually.

The new study, "Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets," found that with expected product introductions and continuing clinical penetration, the now $3 to $4 billion industry, will approach almost $13 billion by 2008.

"Unlike other big-ticket drug areas, competition is limited in this market because of the very specific target each product is approved for," notes Melissa Elder, author of the report. "However, even if one area is being target well, such as Genentech in lymphoma, other areas, such as lung cancer, are considerably in need of attention. There is plenty of opportunity."

At least two (and as many as five) emerging monoclonal antibody-based cancer products will hit the market in 2005 according to the report which reviews over 120 products in currently in development. The study covers these emerging product and currently available treatments in eight oncology areas, projecting product launches, revenues, and competitive market positions of the major developers.

This new report is priced at $3500 and is available for purchase at http://www.kaloramainformation.com/pub/953907.html.

About Kalorama Information
Kalorama Information, an imprint of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or sheffner@kaloramainformation.com, or visit www.KaloramaInformation.com.

About MarketResearch.com
MarketResearch.com is the leading provider of global market intelligence products and services. With over 70,000 research publications from 350 research publishers, we offer instant online access to the world’s most extensive database of expert insights on global industries. Updated daily. For more information, contact Matthew Seward at 301-468-3650 x205 or mseward@marketresearch.com, or visit www.MarketResearch.com.

Article Pages:  1  




  Article Comments   Add Comment | View All (0)
    There are currently no comments for this article.


Advanced Search

Good Resources

Create a Happier Life

Diabetes Diet

High Protein, Low Cal Food


Affiliate With Us
 


All content © 2008 Webmaster, Monoclonal Antibody Therapies Continue Rapid Growth in Cancer Market :: Health-Informant.com.